One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum A...
Singapore: Asia has earned the status of a fast growing market for clinical research due to its diverse population, fast...
Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a gro...
In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Th...
Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutica...
Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing ...
Sino Biopharmaceutical, an integrated name in R&D, manufacturing and marketing of health enhancing modernized Chin...
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...
To enhance its market opportunities and drive business growth, China Resources Sanjiu Medical & Pharmaceutical is ...
The global life science industry has been facing a financial crunch and The United Laboratories too has felt the jolt....
Singapore: The healthcare industry is at a disruptive stage globally and patient's involvement and engagement in their o...
North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally eng...
Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a...
Mindray Medical International is emerging as a global name in the medical devices industry, marking 25 percent growth in...
A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disor...
Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
